InvestLog
GLUE logo

GLUE

Monte Rosa Therapeutics, Inc.NASDAQHealthcare
$17.09-0.47%ClosedMarket Cap: $1.11B

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-03-18Wells Fargo—Overweight—
2026-03-18Guggenheim—Buy—
2026-01-14Piper Sandler—Overweight—
2026-01-08Guggenheim—Buy—
2026-01-08Wells Fargo—Overweight—
2025-11-07Wells Fargo—Equal Weight—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-1.69$71.7M5
Sun Dec 31$-1.99$39.0M5
Mon Dec 31$-1.81$123.4M1
Tue Dec 31$-1.31$179.4M1